The incidence rate of testicular cancer has been steadily increasing during the last 50 years, and only cryptorchidism, Le, undescended testes, has been identified as an important risk factor. An interplay between changing environmental factors and genetic susceptibility e.g, in foreign compound metabolizing enzymes, may have important influences on the risk.
Introduction last 50 years. except for men born during World War II, who maintain a reduced lifetime risk (Moller, The incidence of testicular cancer shows a large inter 1993). Despite numerous epidemiological studies in national variation. The incidence rate in Denmark is this field only cryptorchidism has been identified as one of the highest in the world being 8.9 per an important risk factor. and it explains only a minor 100000 per year in 1990 (Parkin et al.. 1992;  fraction of all testicular cancer cases (Forman et aI" Moller. 1993) . and in general the highest incidences 1990; Abratt et al., 1992) , are found in the industrialized countries. In Denmark Brothers of patients with testicular cancer may have the incidence has been steadily increasing during the an up to 12-fold increased risk of developing the dis ease and the risk for bilateral cancer seems higher GSTp, belongs to a multi isoenzyme system with several genetic polymorphisms and importance for detoxification and deactivation of carcinogens (Hayes & Pulford. 1995) . About 50% of Caucasians show a genetical deficiency in GST/L activity due to a deletion in the GSTMl gene (GSTM1*O/Oj (Board, 1981; Seidegaard et al., 1988; Hayes & Pulford. 1995) . This deficiency has been associated with an increased risk for cancer of a number of sites including the lung. bladder. colon. skin and stomach (Hayes & Pulford, 1995; Raunio et al., 1995; Nebert et al., 1996) . To date no data have been published on associations between testicular cancer and GST/L activity.
In this study we examined, if GSTp, deficiency relates to testicular cancer. since this might give some clue about the involvement of environmental carcinogens in testicular cancer.
Materials and methods

Study design
The protocol was approved by the local ethics commit tees, and the study was conducted in accordance with the Declaration of Helsinki. All participants signed informed consent.
A population-based case-control design was employed. Cases of histologically verified testicular cancer were identified from the files of the Danish Cancer Registry and from the in-patient files at the oncological depart ments in the Greater Copenhagen area. Additional eligibility criteria included: unilateral testicular cancer (seminoma or non-seminoma), time of diagnosis January 1, 1989 to June 3D, 1993. age 18-45 at the time of diagnosis. at least 6 months elapsed since any radio-or chemotherapy, Caucasian race, Denmark as the place of birth, alive and living in the Greater Copen hagen area at the time of participation.
Of 238 eligible cases identified, ten were not con tacted: two had died in the intervening period, six were treated for other primary diseases, one had atro phy of the remaining testicle and one had requested not to be contacted by the hospital.
The cases were divided in two groups (seminoma and non-seminoma) according to the histological diagnosis of the tumours. For each group of cases, a group of controls was drawn at random from the Danish National Population Registry with the follow ing eligibility criteria: male. born in Denmark between 1945 and 1973, alive and living in the Greater Vistisen et al.
Copenhagen area at the time of participation. The controls were frequency matched to the cases for the year of birth.
Two hundred and twenty-eight cases and 327 con trols were asked by letter to participate in the investiga tion with one visit at a hospital for interview and collection of blood and urine samples. One hundred and eighty-four cases (80 (76.9%) seminomas, 104 (83.9%) non-seminomas) and 194 (59.3%) controls participated in the investigation. The 184 cases (80.7%) had unilateral orchidectomy 1.0-6.3 years (median = 3.4) before participating. Ninety-two cases (50%) did not receive further treatment. Seventy seven cases (42%) received chemotherapy. 11 (6%) received radiation and only four (2%) received both. At the time of participation all were clinically cured. and a period of 0.5-5.9 years (median 2.3) had passed since termination of treatment witfi chemo therapy or radiation.
All participants delivered blood samples except four men (three cases and one control), who refused to deliver blood, or in whom a venepuncture was impossible due to previous chemotherapy. All partici pants gave information regarding height, weight, their consumption of alcoholic beverages, coffee. tea, cola, the duration of their exercise during the preced ing two weeks, the ingestion of drugs, and whether they suffered from cryptorchidism in their childhood. All tobacco containing items smoked were counted as cigarette-equivalents (Prignot, 1987) . The consump tion of caffeine was estimated as the caffeine index cal culated as the number of cups (150 ml) of coffee plus 0.3 times the number of cups of tea plus 0.18 times the number of cups of cola (Barone & Roberts. 1996).
Blood samples for determination of the pheno-and genotype of GSTp,
The phenotype of the enzyme GSTp, in blood cells was determined once by the commercial ELISA-kit, MUKIT ® (Biotrin International. Ireland). Blood samples were collected by venepuncture in heparinized tubes centri fugated at 350 x g for 10 min and after removal of plasma stored at -20°C until analysis. The GSTp, phenotypes were determined in 366 participants (80 seminomas. 98 non-seminomas and 188 con trols). in eight participants the phenotypes were non determinable (three cases and five controls). The GSTMl genotype was determined twice on the same sample by polymerase chain reaction (PCR) technique as described elsewhere (Autrup et al., 1995) . Blood samples were collected by venepuncture in heparin ized tubes stored at -20°C until analysis. The GSTp, genotypes were determined in 324 participants (79 seminomas, 97 non-seminomas and 148 controls). Height ( 
Statistical analysis
The demographic values (age. height. weight, con sumption of alcohol, caffeine and tobacco and amount of exercising) of the groups were compared by means of the Mann-Whitney U test. The frequencies of the GSTtl phenotype and GSTMI genotype were compared between the groups by the X 2 test. For all statistical evaluations, a two-sided p value of 0.05 was considered to be statistically significant. The odds ratios (OR) with 95% confidence intervals for each type of testicular cancer and the types combined were estimated for the GSTtl negative phenotype and the GSTMI null genotype by comparison with the respective control group.
Results
The cases and controls were similar with respect to age. height and weight, the daily consumption of bev erages containing alcohol or caffeine and the duration of exercise during the preceding 2 weeks ( Tables 2 and 3 show the frequencies of the GSTtl phenotypes and the GSTMI genotypes in controls and in the groups of seminomas. non-seminomas and all cases, no significant differences were found. The ORs of having the GSTtl negative phenotype and testi cular cancer ranged from 0.91-1.34. no significant associations were found ( Table 2 ). The ORs of having the GSTMI null genotype and testicular cancer ranged from 0.84-1. 54. no significant associations were found (Table 3) .
Among the controls 55% were phenotypically defi cient in respect to the GSTtl isoenzyme. and the fre quency of the GSTMI null genotype in the group of controls was 49%. In 319 men both the geno-and the phenotype were determined. and the concor dance between the geno-and the phenotype was 94.4 % (14/319 had no in vivo enzyme activity and no mutation at the locus of GSTMI, and 4/319 had in vivo enzyme activity and the GSTMI null genotype).
When stratifying on smoking habits. the ORs of having testicular cancer and GSTtl negative phenotype Vistisen et al. were 0.98 CI 9 5 ,y' , (0.53-1.80) for smokers and 1.18 CI 9 5 % (0.67-2.08) for non-smokers.
Among the cases with either seminoma or non seminoma a significantly higher proportion reported suffering from cryptorchidism in their childhood, as compared to the corresponding control group ( Table 4) . The OR of having testicular cancer in men reporting cryptorchidism was significant 3.77 CI 9 5 % (1.97-7.21).
Discussion
In this study we investigated a possible association between GSTfl. deficiency and testicular cancer. To our knowledge, this is the first case-control study relating tes ticular cancer to the metabolic capacity for activation or inactivation of carcinogens. Although our finding is negative, it is still possible that other enzymes activating or inactivating carcinogens could be risk factors and thus might help understanding the familiar occurrence, the geographical variation, the rapidly increasing incidence and the relation to environmental chemicals.
The use of central population and cancer registries with complete registration and the high rate of partici pation minimize the potential risk of bias of selection.
The validity of the study was further strengthened because all the participants were drawn from the racially homogeneous population of men born in Den mark, In this setting the narrow confidence intervals of the ORs overlapping one indicate, that GSTfl. deficiency is not a risk factor for testicular cancer.
The results in the group of controls confirm previous studies, showing that 55% are phenotypically deficient in respect to the GSTfl. isoenzyme (Brockmoller et al., 1994) . The frequency of the GSTMl null genotype in the controls was 49%, which agrees with the single previously published study in Denmark (Autrup et al., 1995) . Our study showed 94.4% concordance between the geno-and phenotype in agreement with previous studies showing 90-99% accordance (Brock moiler et al., 1993) . In the present study re-testing was not possible. Taking the genotypes as the 'true measure', 14 were false negative and four were false positive. This could be due to environmental factors not identified in this study. Some drugs such as etha crynic acid and indomethacin are well-known inhibi tors of glutathione S-transferases (Hansson et al., 1991; Beckett & Hayes, 1993) . In this study the parti cipants did not use any of these drugs at the time of partcipation.
Cryptorchidism has been shown to be a risk factor for testicular cancer (Forman et al., 1990) . The present study confirmed this showing that the study had suffi cient statistical power to detect risk factors. GSTp, is distributed in many tissues. mainly in the liver but also in the testicular tissue and testicular tumours (Klys et al.. 1992) . GSTp, exists in five subclasses. GSTM1-S. GSTM3 and 4 have been shown in testicular tissue (Campbell et al., 1990 : Morel et al., 1994 . In our study we determined the null GSTMI genotype corre sponding to the GSTp, phenotype in blood.
Exposure to specific chemical(s) in susceptible indi viduals could be responsible for the development of many cancer diseases. and the importance of investi gating the distributions of the polymorphically activat ing and deactivating (defence) enzymes is obvious. With narrow confidence intervals this study did not show signs of any association between testicular cancer and the polymorphism of GSTp,. Specific com pounds (carcinogens) inactivated by GSTIt are not likely to be involved in the development of testicular cancer.
